Literature DB >> 2708333

The binding of isocolchicine to tubulin. Mechanisms of ligand association with tubulin.

S B Hastie1, R C Williams, D Puett, T L Macdonald.   

Abstract

Isocolchicine is a structurally related isomer of colchicine altered in the methoxytropone C ring. In spite of virtual structural homology of colchicine and isocolchicine, isocolchicine is commonly believed to be inactive in binding to tubulin and inhibiting microtubule assembly. We have found that isocolchicine does indeed bind to the colchicine site on tubulin, as demonstrated by its ability to competitively inhibit [3H]colchicine binding to tubulin with a KI approximately 400 microM. Isocolchicine inhibits tubulin assembly into microtubules with an I50 of about 1 mM, but the affinity of isocolchicine for the colchicine receptor site, 5.5 +/- 0.9 x 10(3) M-1 at 23 degrees C, is much less (approximately 500-fold) than that of colchicine. Unlike colchicine, isocolchicine binds rapidly, and the absorption and fluorescence properties of the complex are only modestly altered compared to free ligand. It is proposed that the binding of isocolchicine to tubulin may be rationalized either in terms of conformational states of colchicinoids when liganded to tubulin or by the structural requirements for C-10 substituents for high affinity binding to the colchicine receptor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2708333

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Pyrrole-Based Antitubulin Agents: Two Distinct Binding Modalities are Predicted for C-2 Analogs in the Colchicine Site.

Authors:  Chenxiao Da; Nakul Telang; Peter Barelli; Xin Jia; John T Gupton; Susan L Mooberry; Glen E Kellogg
Journal:  ACS Med Chem Lett       Date:  2011-11-01       Impact factor: 4.345

2.  Mechanism of tubulin-colchicine recognition: a kinetic study of the binding of the colchicine analogues colchicide and isocolchicine.

Authors:  C Dumortier; Q Yan; S Bane; Y Engelborghs
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

3.  Syntheses and biological evaluation of ring-C modified colchicine analogs.

Authors:  Baiyuan Yang; Zhiqing C Zhu; Holly V Goodson; Marvin J Miller
Journal:  Bioorg Med Chem Lett       Date:  2010-03-15       Impact factor: 2.823

4.  Antihelminthic benzimidazoles are novel HIF activators that prevent oxidative neuronal death via binding to tubulin.

Authors:  Hossein Aleyasin; Saravanan S Karuppagounder; Amit Kumar; Sama Sleiman; Manuela Basso; Thong Ma; Ambreena Siddiq; Shankar J Chinta; Camille Brochier; Brett Langley; Renee Haskew-Layton; Susan L Bane; Gregory J Riggins; Irina Gazaryan; Anatoly A Starkov; Julie K Andersen; Rajiv R Ratan
Journal:  Antioxid Redox Signal       Date:  2015-01-10       Impact factor: 8.401

5.  Synthesis, Antiproliferative Activity and Molecular Docking Studies of Novel Doubly Modified Colchicine Amides and Sulfonamides as Anticancer Agents.

Authors:  Julia Krzywik; Witold Mozga; Maral Aminpour; Jan Janczak; Ewa Maj; Joanna Wietrzyk; Jack A Tuszyński; Adam Huczyński
Journal:  Molecules       Date:  2020-04-14       Impact factor: 4.411

6.  Synthesis and Antiproliferative Screening Of Novel Analogs of Regioselectively Demethylated Colchicine and Thiocolchicine.

Authors:  Dominika Czerwonka; Szymon Sobczak; Ewa Maj; Joanna Wietrzyk; Andrzej Katrusiak; Adam Huczyński
Journal:  Molecules       Date:  2020-03-05       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.